Drug Approval | December 27, 2025
EU nod to Wayrilz as breakthrough treatment for hard-to-treat ITP
Wayrilz represents a new approach to ITP by targeting the disease at its root through multi-immune modulation
Wayrilz represents a new approach to ITP by targeting the disease at its root through multi-immune modulation
Launches National IVD validation portal and protocols; highlights India’s strengthening health research ecosystem
ITP is a disease of complex immune dysregulation leading to low platelet counts, bleeding, and reduced quality of life
CSIR-IGIB advances indigenous CRISPR Trials on sickle cell anaemia, anti-microbial resistance, liver fibrosis and rare disorders
In light of the contributions of these three institutes, it was decided to organize a CSIR Startup Conclave in Hyderabad. The event, scheduled for April 22–23, 2025
PiaSky advances C5 inhibition through innovative recycling technology, which enables its monthly SC administration
PiaSky advances C5 inhibition through innovative recycling technology, which enables its monthly SC administration
The period from 2020 to 2022 witnessed a remarkable surge in deal worth
We are achieving the target of developed India by making our young children healthy today
Launches collaborative centre for translational research in head and neck cancer
Subscribe To Our Newsletter & Stay Updated
